CENTRE D'ETUDE ET DE TRAITEMENT EN OPHTALMOLOGIE
0826.214.623 · rovalta.com · 28/09/2026
CENTRE D'ETUDE ET DE TRAITEMENT EN OPHTALMOLOGIE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCENTRE D'ETUDE ET DE TRAITEMENT EN OPHTALMOLOGIE is a Private limited company incorporated in 2010. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Bruxelles. It employs on average 5,7 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0826.214.623
- Incorporation
- 28/05/2010
- Legal form
- Private limited company
- Registered office
- Avenue du Pérou 79
1000 Bruxelles · BruxellesSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 5,7 ETP
Joint committees (1)
- 330
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,8 M € | +40.5% | 1,3 M € | +0.5% | 1,3 M € | +71.8% | 734,1 k € | +23.1% | 596,5 k € |
| EBITDA | 1,5 M € | +48.9% | 1 M € | -2.4% | 1 M € | +93.9% | 531 k € | +34.6% | 394,4 k € |
| Operating result | 1,4 M € | +53.4% | 908,7 k € | -2.8% | 934,9 k € | +126% | 413 k € | +77.4% | 232,9 k € |
| Net result | 973,6 k € | +57.2% | 619,2 k € | -1.3% | 627,5 k € | +109% | 299,9 k € | +97.2% | 152,1 k € |
| Balance sheet | |||||||||
| Equity | 2,3 M € | +16.3% | 2 M € | +33.5% | 1,5 M € | +48.4% | 1 M € | +6.2% | 946,5 k € |
| Total assets | 3 M € | +7.1% | 2,8 M € | +17.4% | 2,4 M € | +24.4% | 1,9 M € | +9.2% | 1,8 M € |
| Cash | 319 k € | -79.5% | 1,6 M € | +16.4% | 1,3 M € | +76.9% | 755,6 k € | -13.9% | 877,5 k € |
| Debts | 673 k € | -15.7% | 798 k € | -9.9% | 885,4 k € | -2.3% | 906,2 k € | +12.7% | 804,1 k € |
| Other | |||||||||
| Workforce | 5,7 ETP | +18.8% | 4,8 ETP | -4.0% | 5,0 ETP | -7.4% | 5,4 ETP | -10.0% | 6,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director01/01/2019 → 01/01/2029Manager01/01/2016 → 01/01/2024ended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Quentin SCHEPENS | Manager |
Other companies at this address
Avenue du Pérou 79 1000 Bruxelles| Company | CBE no. |
|---|---|
ADVOCATENKANTOOR DEKEYSER CAROLINE● Liquidation | 0475.941.287 |
Andre et Cie● Active | 0402.053.617 |
| 0858.379.031 | |
Centrale Financière et Commerciale● Liquidation | 0403.260.474 |
GAUTHIER SCHEPENS● Active | 0874.572.091 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/08/2026 | 29/08/2025 | 30/08/2024 | 31/08/2023 | 01/09/2022 | 29/10/2021 |
| General meeting | 25/06/2026 | 26/06/2025 | 27/06/2024 | 29/06/2023 | 30/06/2022 | 24/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 25/06/2026 | 03/08/2026 | French | |
| Abridged model | 31/12/2024 | 26/06/2025 | 29/08/2025 | French | |
| Abridged model | 31/12/2023 | 27/06/2024 | 30/08/2024 | French | |
| Abridged model | 31/12/2022 | 29/06/2023 | 31/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/06/2022 | 01/09/2022 | French | |
| Abridged model | 31/12/2020 | 24/06/2021 | 29/10/2021 | French | |
| Abridged model | 31/12/2019 | 25/06/2020 | 25/08/2020 | French | |
| Abridged model | 31/12/2018 | 27/06/2019 | 30/08/2019 | French | |
| Abridged model | 31/12/2017 | 28/06/2018 | 31/08/2018 | French | |
| Abridged model | 31/12/2016 | 29/06/2017 | 27/09/2017 | French | |
| Abridged model | 31/12/2015 | 30/06/2016 | 29/09/2016 | French | |
| Abridged model | 31/12/2014 | 25/06/2015 | 25/08/2015 | French | |
| Abridged model | 31/12/2013 | 16/05/2014 | 21/10/2014 | French | |
| Abridged model | 31/12/2012 | 17/05/2013 | 25/06/2013 | French | |
| Abridged model | 31/12/2011 | 18/05/2012 | 29/05/2012 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director01/01/2019 → 01/01/2029Manager01/01/2016 → 01/01/2024ended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Quentin SCHEPENS | Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates16/01/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Mandates22/01/2019DEMISSIONS, NOMINATIONS
- Other29/03/2018OBJET
- Mandates04/01/2016DEMISSIONS, NOMINATIONS
- Other08/06/2010RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue du Pérou 79, 1000 BrusselsCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00379373 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| CENTRE D'ETUDE ET DE TRAITEMENT EN OPHTALMOLOGIECurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00379373 |
Events
- 2025Annual accounts 2025973,6 k €↑
- 2024Annual accounts 2024619,2 k €↓
- 2023Annual accounts 2023627,5 k €↑
- 2022Annual accounts 2022299,9 k €↑
- 2021Annual accounts 2021152,1 k €↓
- 2020Annual accounts 2020198,3 k €↑
- 2019Annual accounts 2019119,4 k €↓
- 2018Annual accounts 2018140,4 k €↑
- 2017Annual accounts 2017139 k €↑
- 2016Annual accounts 201666,3 k €↑
- 2015Annual accounts 201535,7 k €↓
- 2014Annual accounts 201452,7 k €↑
- 2013Annual accounts 201351 k €↑
- 2012Annual accounts 201225,6 k €↑
- 2011Annual accounts 2011-40,4 k €
- 28/05/2010IncorporationPrivate limited company